Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-02-29 4:32 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead | 0 | $0 | 278,522 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 4:44 pm | N/A 2033-09-29 | KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director | 0 | $0 | 5,000 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 8:13 pm | N/A 2033-03-03 | KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2022-02-04 Tax Withholding | 2022-02-08 8:40 pm | N/A N/A | AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer | 927 | $7.05 | 30,749 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:02 pm | N/A 2032-02-01 | KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-11-11 Tax Withholding | 2021-11-15 4:44 pm | N/A N/A | AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer | 2,162 | $12.06 | 31,676 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 6:07 pm | N/A 2031-02-04 | AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer | 61,000 | $0 | 83,838 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-12 5:05 pm | N/A N/A | AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer | 2,162 | $13.05 | 22,838 (Direct) | View |
| 2019-11-11 Option Award | 2019-11-13 4:08 pm | N/A 2029-11-11 | AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer | 135,000 | $0 | 135,000 (Direct) | View |